- Home
- DNA vs MEGI Comparison
DNA vs MEGI Comparison
Compare DNA & MEGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNA
- MEGI
- Stock Information
- Founded
- DNA 2008
- MEGI 2021
- Country
- DNA United States
- MEGI United States
- Employees
- DNA N/A
- MEGI N/A
- Industry
- DNA Biotechnology: Biological Products (No Diagnostic Substances)
- MEGI Investment Managers
- Sector
- DNA Health Care
- MEGI Finance
- Exchange
- DNA Nasdaq
- MEGI Nasdaq
- Market Cap
- DNA 658.5M
- MEGI 729.7M
- IPO Year
- DNA N/A
- MEGI N/A
- Fundamental
- Price
- DNA $9.42
- MEGI $14.35
- Analyst Decision
- DNA Sell
- MEGI
- Analyst Count
- DNA 3
- MEGI 0
- Target Price
- DNA $9.67
- MEGI N/A
- AVG Volume (30 Days)
- DNA 1.6M
- MEGI 178.0K
- Earning Date
- DNA 08-07-2025
- MEGI 01-01-0001
- Dividend Yield
- DNA N/A
- MEGI 11.40%
- EPS Growth
- DNA N/A
- MEGI N/A
- EPS
- DNA N/A
- MEGI N/A
- Revenue
- DNA $237,417,000.00
- MEGI N/A
- Revenue This Year
- DNA N/A
- MEGI N/A
- Revenue Next Year
- DNA $15.91
- MEGI N/A
- P/E Ratio
- DNA N/A
- MEGI N/A
- Revenue Growth
- DNA 13.76
- MEGI N/A
- 52 Week Low
- DNA $5.00
- MEGI $10.63
- 52 Week High
- DNA $16.85
- MEGI $14.89
- Technical
- Relative Strength Index (RSI)
- DNA 51.44
- MEGI 58.45
- Support Level
- DNA $9.75
- MEGI $14.06
- Resistance Level
- DNA $13.33
- MEGI $14.41
- Average True Range (ATR)
- DNA 0.87
- MEGI 0.19
- MACD
- DNA -0.18
- MEGI -0.00
- Stochastic Oscillator
- DNA 28.59
- MEGI 74.53
About DNA Ginkgo Bioworks Holdings Inc.
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering: where company provide biological R&D services for customers across a range of industries and Biosecurity: where it provide services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.
About MEGI MainStay CBRE Global Infrastructure Megatrends Term Fund
NYLI CBRE Global Infrastructure Megatrends Term Fund is a non-diversified, closed-end management investment company. The Fund's investment objective is to seek a high level of total return with an emphasis on current income. It is focused on the investment megatrends of decarbonization, digital transformation and asset modernization, which are reshaping the demand for infrastructure assets and driving income and growth potential.